Literature DB >> 20390484

Acceptability and challenges of implementing voluntary counselling and testing (VCT) in rural Zimbabwe: evidence from the Regai Dzive Shiri Project.

Petronella Chirawu1, Lisa Langhaug, Webster Mavhu, Sophie Pascoe, Jeffrey Dirawo, Frances Cowan.   

Abstract

Voluntary counselling and testing (VCT) is an important component of HIV prevention and care. Little research exists on its acceptability and feasibility in rural settings. This paper examines the acceptability and feasibility of providing VCT using data from two sub-studies: (1) client-initiated VCT provided in rural health centres (RHCs) and (2) researcher-initiated VCT provided in a non-clinic community setting. Nurses provided client-initiated VCT in 39 RHCs in three Zimbabwean provinces (2004-2007). Demographic data and HIV status were collected. Qualitative data were also collected to assess rural communities' impressions of services. In a second study in 2007, VCT was offered to participants in a population-based HIV prevalence survey. Quantitative data from clinic-based VCT show that of 3585 clients aged > or =18, 79.4% (95% CI: 78.0-80.7%) were female; young people (aged 18-24) comprised 21.1%. Overall, 32.9% (95% CI: 31.4-34.5%) tested HIV positive. Young people were less likely to be HIV positive 13.5% (95% CI: 11.1-16.1%) vs. 38.1% (95% CI: 36.3-39.9%). In the second study conducted in a non-clinic setting, 27.0% (n=1368/5052) of participants opted to test. Young people were as likely to test as adults (27.3% vs. 26.9%) and an equal proportion of men and women tested. Overall during the second survey, 18.8% (95% CI: 16.7-21.0%) of participants tested positive (youth = 8.4% (95% CI: 6.4-10.7%); adults = 29.1% (95% CI: 25.7-32.7%)). Qualitative data, unique to clinics only, suggested that adults identify RHCs as acceptable VCT sites, whereas young people expressed reservations around these venues. Males reported considering VCT only after becoming ill. While VCT offered through RHCs is acceptable to women, it seems that men and youth are less comfortable with this venue. When VCT was offered in a non-clinic setting, numbers of men and women testing were similar. These data suggest that it may be possible to improve testing uptake in rural communities using non-clinic settings.

Entities:  

Mesh:

Year:  2010        PMID: 20390484     DOI: 10.1080/09540120903012577

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  27 in total

1.  Facilitators and barriers related to voluntary counseling and testing for HIV among young adults in Bo, Sierra Leone.

Authors:  Shalinee Bhoobun; Anuradha Jetty; Mohamed A Koroma; Mohamed J Kamara; Mohamed Kabia; Reginald Coulson; Rashid Ansumana; Kathryn H Jacobsen
Journal:  J Community Health       Date:  2014-06

2.  What motivates use of community-based human immunodeficiency virus testing in rural South Africa?

Authors:  Devesh Upadhya; Anthony P Moll; Ralph P Brooks; Gerald Friedland; Sheela V Shenoi
Journal:  Int J STD AIDS       Date:  2015-07-01       Impact factor: 1.359

3.  Who gets tested for HIV in a South African urban township? Implications for test and treat and gender-based prevention interventions.

Authors:  Kartik K Venkatesh; Precious Madiba; Guy De Bruyn; Mark N Lurie; Thomas J Coates; Glenda E Gray
Journal:  J Acquir Immune Defic Syndr       Date:  2011-02-01       Impact factor: 3.731

4.  HIV testing uptake among the household contacts of multidrug-resistant tuberculosis index cases in eight countries.

Authors:  V S Opollo; X Wu; M D Hughes; S Swindells; A Gupta; A Hesseling; G Churchyard; S Kim; R Lando; R Dawson; V Mave; A Mendoza; P Gonzales; N Kumarasamy; F von Groote-Bidlingmaier; F Conradie; J Shenje; S N Fontain; A Garcia-Prats; A Asmelash; S Nedsuwan; L Mohapi; R Mngqibisa; A C Garcia Ferreira; E Okeyo; L Naini; L Jones; B Smith; N S Shah
Journal:  Int J Tuberc Lung Dis       Date:  2018-12-01       Impact factor: 2.373

5.  Health care utilization and access to human immunodeficiency virus (HIV) testing and care and treatment services in a rural area with high HIV prevalence, Nyanza Province, Kenya, 2007.

Authors:  Marta-Louise Ackers; Allen Hightower; David Obor; Peter Ofware; Lilian Ngere; Adazu Kubaje; Kayla F Laserson
Journal:  Am J Trop Med Hyg       Date:  2013-12-09       Impact factor: 2.345

Review 6.  Should trained lay providers perform HIV testing? A systematic review to inform World Health Organization guidelines.

Authors:  C E Kennedy; P T Yeh; C Johnson; R Baggaley
Journal:  AIDS Care       Date:  2017-04-24

Review 7.  Systematic review and meta-analysis of community and facility-based HIV testing to address linkage to care gaps in sub-Saharan Africa.

Authors:  Monisha Sharma; Roger Ying; Gillian Tarr; Ruanne Barnabas
Journal:  Nature       Date:  2015-12-03       Impact factor: 49.962

Review 8.  A systematic review of qualitative findings on factors enabling and deterring uptake of HIV testing in Sub-Saharan Africa.

Authors:  Maurice Musheke; Harriet Ntalasha; Sara Gari; Oran McKenzie; Virginia Bond; Adriane Martin-Hilber; Sonja Merten
Journal:  BMC Public Health       Date:  2013-03-11       Impact factor: 3.295

9.  Uptake of voluntary counselling and testing among young people participating in an HIV prevention trial: comparison of opt-out and opt-in strategies.

Authors:  Kathy Baisley; Aoife M Doyle; John Changalucha; Kaballa Maganja; Deborah Watson-Jones; Richard Hayes; David Ross
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

10.  Relative efficiency of demand creation strategies to increase voluntary medical male circumcision uptake: a study conducted as part of a randomised controlled trial in Zimbabwe.

Authors:  Collin Mangenah; Webster Mavhu; Diego Cerecero Garcia; Chiedza Gavi; Polite Mleya; Progress Chiwawa; Sandra Chidawanyika; Getrude Ncube; Sinokuthemba Xaba; Owen Mugurungi; Noah Taruberekera; Ngonidzashe Madidi; Katherine L Fielding; Cheryl Johnson; Karin Hatzold; Fern Terris-Prestholt; Frances M Cowan; Sergio Bautista-Arredondo
Journal:  BMJ Glob Health       Date:  2021-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.